Cargando…

Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial

AIMS: Heart failure (HF) is a multifactorial disease. Current treatments target only a fraction of the putative pathophysiological pathways. In patients with HF, reduced cardiac output and congestion cause increased gut wall permeability. It has been suggested that leakage of microbial products is d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mayerhofer, Cristiane C.K., Awoyemi, Ayodeji O., Moscavitch, Samuel D., Lappegård, Knut Tore, Hov, Johannes R., Aukrust, Pål, Hovland, Anders, Lorenzo, Andrea, Halvorsen, Sigrun, Seljeflot, Ingebjørg, Gullestad, Lars, Trøseid, Marius, Broch, Kaspar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Study Designs
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165929/ https://www.ncbi.nlm.nih.gov/pubmed/30088346 http://dx.doi.org/10.1002/ehf2.12332

Ejemplares similares

Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
por: Awoyemi, Ayodeji, et al.
Publicado: (2021)

Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
por: Nendl, Andraž, et al.
Publicado: (2023)

Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2019)

Low fibre intake is associated with gut microbiota alterations in chronic heart failure
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2020)

Gut related inflammation and cardiorespiratory fitness in patients with CAD and type 2 diabetes: a sub-study of a randomized controlled trial on exercise training
por: Aune, Susanne Kristine, et al.
Publicado: (2021)

The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
por: Trøseid, Marius, et al.
Publicado: (2020)

Gut Leakage Markers in Response to Strenuous Exercise in Patients with Suspected Coronary Artery Disease
por: Aune, Susanne Kristine, et al.
Publicado: (2021)

Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study
por: Awoyemi, Ayodeji, et al.
Publicado: (2018)

Rosuvastatin alters the genetic composition of the human gut microbiome
por: Kummen, Martin, et al.
Publicado: (2020)

Rationale and design of the EPCHF trial: the early palliative care in heart failure trial (EPCHF)
por: Becher, Marc Ulrich, et al.
Publicado: (2021)

Effect of melatonin on heart failure: design for a double‐blinded randomized clinical trial
por: Sadeghi, Masoumeh, et al.
Publicado: (2020)

Rationale and design of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary heart disease 2 trial (CE-MARC 2): A prospective, multicenter, randomized trial of diagnostic strategies in suspected coronary heart disease
por: Ripley, David P., et al.
Publicado: (2015)

Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction
por: Hoel, Hedda, et al.
Publicado: (2018)

Rationale and design of the EMPERIAL‐Preserved and EMPERIAL‐Reduced trials of empagliflozin in patients with chronic heart failure
por: Abraham, William T., et al.
Publicado: (2019)

Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial
por: Solomon, Scott D., et al.
Publicado: (2021)

Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
por: Hundertmark, Moritz J., et al.
Publicado: (2021)

The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)
por: Wiggers, Henrik, et al.
Publicado: (2021)

Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial
por: ter Maaten, Jozine M., et al.
Publicado: (2022)

The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs
por: Thompson, Jennifer A, et al.
Publicado: (2017)

Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE‐HF) trial
por: Keene, Daniel, et al.
Publicado: (2018)

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
por: Scheffer, Mariëlle, et al.
Publicado: (2020)

Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort study
por: Zelenak, Christine, et al.
Publicado: (2023)

Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: rationale and design of SHIFT‐AHF trial
por: Su, Yang, et al.
Publicado: (2020)

PRADOC: a trial on the efficiency of a transition care management plan for hospitalized patients with heart failure in France
por: Duflos, Claire, et al.
Publicado: (2020)

The development and description of the comparison group in the Look AHEAD trial
Publicado: (2011)

Inferior vena cava ultrasound in acute decompensated heart failure: design rationale of the CAVA‐ADHF‐DZHK10 trial
por: Jobs, Alexander, et al.
Publicado: (2020)

Design of a prospective patient‐level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure
por: Packer, Milton, et al.
Publicado: (2020)

Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer
por: Brown, Louise C, et al.
Publicado: (2022)

Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial
por: Tromp, Jasper, et al.
Publicado: (2021)

Personalized pacing for diastolic dysfunction and heart failure with preserved ejection fraction: Design and rationale for the myPACE randomized controlled trial
por: Infeld, Margaret, et al.
Publicado: (2021)

Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial
por: Butler, Javed, et al.
Publicado: (2021)

Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
por: Jørgensen, S. F., et al.
Publicado: (2019)

Redesigning a large school-based clinical trial in response to changes in community practice
por: Gerald, Lynn B, et al.
Publicado: (2011)

The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study
por: Ekström, Mattias, et al.
Publicado: (2020)

Beta‐blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve‐HR trial)
por: Palau, Patricia, et al.
Publicado: (2020)

Randomized trials of alcohol-use interventions with college students and their parents: lessons from the Transitions Project
por: Fernandez, AC, et al.
Publicado: (2011)

EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country
por: Mooney, Thomas, et al.
Publicado: (2018)

Challenges and opportunities for conducting a vaccine trial during the COVID-19 pandemic in the United Kingdom
por: Török, M Estée, et al.
Publicado: (2021)

Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
por: Helseth, Ragnhild, et al.
Publicado: (2021)

Catheter ablation for atrial fibrillation in patients with end‐stage heart failure and eligibility for heart transplantation
por: Sohns, Christian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jsb9e4rpjcrfifdm6tbhf4hcnr